1. Home
  2. BXP vs CRL Comparison

BXP vs CRL Comparison

Compare BXP & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boston Properties Inc.

BXP

Boston Properties Inc.

HOLD

Current Price

$68.87

Market Cap

11.1B

Sector

Real Estate

ML Signal

HOLD

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$223.24

Market Cap

10.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BXP
CRL
Founded
1970
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Commercial Physical & Biological Resarch
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1B
10.8B
IPO Year
1999
1999

Fundamental Metrics

Financial Performance
Metric
BXP
CRL
Price
$68.87
$223.24
Analyst Decision
Buy
Buy
Analyst Count
18
12
Target Price
$71.94
$198.27
AVG Volume (30 Days)
1.2M
796.7K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
4.86%
N/A
EPS Growth
1833.33
N/A
EPS
0.64
N/A
Revenue
$3,482,279,000.00
$1,857,601,000.00
Revenue This Year
$11.00
N/A
Revenue Next Year
$2.91
$3.04
P/E Ratio
$108.14
N/A
Revenue Growth
2.19
10.48
52 Week Low
$49.93
$144.26
52 Week High
$79.33
$238.85

Technical Indicators

Market Signals
Indicator
BXP
CRL
Relative Strength Index (RSI) 57.95 58.22
Support Level $68.20 $218.39
Resistance Level $70.54 $232.94
Average True Range (ATR) 1.55 8.15
MACD -0.18 -2.14
Stochastic Oscillator 52.79 45.70

Price Performance

Historical Comparison
BXP
CRL

About BXP Boston Properties Inc.

BXP owns 179 properties consisting of approximately 52.6 million rentable square feet of space. The portfolio is dominated by office buildings and is spread across major cities such as New York, Boston, San Francisco, Los Angeles, Seattle, and the Washington, D.C., region. The real estate investment trust also owns limited retail, hotel, and residential properties.

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: